Survival difference between high-risk and low-risk CFTR genotypes after lung transplant-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival difference between high-risk and low-risk CFTR genotypes after lung transplant

Published:2022-10 Issue:10 Volume:41 Page:1511-1519
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Clausen Emily S.,Weber Jeremy M.,Neely Megan L.,Ramos Kathleen J.,Snyder Laurie D.

Funder

CHEST Foundation

Cystic Fibrosis Foundation Therapeutics

National Institutes of Health

Cystic Fibrosis Foundation

United Network for Organ Sharing

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference31 articles.

1. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation;Ramsey;N Engl J Med,2011

2. Elexacaftor-Tezacaftor-Ivacaftor for cystic fibrosis with a single Phe508del Allele;Middleton;N Engl J Med,2019

3. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: A double-blind, randomised, phase 3 trial;Heijerman;Lancet,2019

4. Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation;Thabut;Am J Respir Crit Care Med,2013

5. Lung transplantation and survival in children with cystic fibrosis;Liou;N Engl J Med,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Year in Cardiothoracic Transplant Anesthesia: Selected Highlights From 2022 Part I: Lung Transplantation;Journal of Cardiothoracic and Vascular Anesthesia;2024-05

2. Cystic fibrosis survival outcomes following second lung transplant: The north American experience;Clinical Transplantation;2023-08-10

3. Erratum to Survival difference between high-risk and low-risk CFTR genotypes after lung transplant. J Heart Lung Transpl 2022;41(10):1511-19. https://doi.org/10.1016/j.healun.2022.04.009;The Journal of Heart and Lung Transplantation;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3